13F HOLDINGS REPORT
Wildcat Capital Management, LLC
Quarter ended Q2 2025 · Filed July 18, 2025 · Accession 0001999371-25-009410
Total Value
$168.3M
Positions
6
Other Managers
0
Confidential Omitted
No
Holdings (6)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | FRONTIER GROUP HLDGS INC | ULCC | 28,061,351 | $101.9M | 60.52% |
| 2 | RLX TECHNOLOGY INC | RLX | 18,046,195 | $39.9M | 23.70% |
| 3 | ACUREN CORP | TICAW | 1,500,000 | $16.6M | 9.84% |
| 4 | UROGEN PHARMA LTD | URGN | 495,606 | $6.8M | 4.03% |
| 5 | ALLOGENE THERAPEUTICS INC | ALLO | 2,920,787 | $3.1M | 1.85% |
| 6 | SILEXION THERAPEUTICS CORP | SLXNW | 113,428 | $91,877 | 0.05% |